1. Hormones and heart disease in women: Where are we in 2005?

   • Elizabeth Barrett-Connor

   Invited Commentary Pages: 85 - 87

2. Clinical trials report

   • John A. Farmer

   OriginalPaper Pages: 91 - 93

3. The good fat hormone: Adiponectin and cardiovascular disease

   • Dat Do
   • Jorge Alvarez
   • Robert Chilton

   OriginalPaper Pages: 94 - 99

4. Homocysteine: Role and implications in atherosclerosis

   • Sasidhar Guthikonda
   • William G. Haynes

   OriginalPaper Pages: 100 - 106

5. Triglycerides and remnant particles as risk factors for coronary artery disease

   • Takamitsu Nakamura
   • Kiyotaka Kugiyama

   OriginalPaper Pages: 107 - 110

6. Behavioral cardiology: Recognizing and addressing the profound impact of psychosocial stress on cardiovascular health

   • Sajal Das
   • James H. O’Keefe

   OriginalPaper Pages: 111 - 118

7. Cardiac allograft vasculopathy: The achilles’ heel of long-term survival after cardiac transplantation

   • Amandeep Dhaliwal
   • Vinay Thohan

   OriginalPaper Pages: 119 - 130

8. Imaging of atherosclerosis using magnetic resonance: State of the art and future directions

   • Milind Y. Desai
   • João A. C. Lima

   OriginalPaper Pages: 131 - 139

9. Optical coherence tomography and its use in detection of vulnerable plaque

   • Mehmet Cilingiroglu
   • Kerem Ozer

   OriginalPaper Pages: 140 - 143

10. Adiposopathy is a more rational treatment target for metabolic disease than obesity alone

    • Harold Bays
    • Carlos A. Dujovne

    OriginalPaper Pages: 144 - 156

11. Optimal low-density lipoprotein levels: Evidence from epidemiology and clinical trials

    • Josh Todd
    • John A. Farmer

    OriginalPaper Pages: 157 - 162

12. Recombinant apolipoprotein A-I_Milano for the treatment of cardiovascular diseases

    • Laura Calabresi
    • Cesare R. Sirtori
    • Guido Franceschini

    OriginalPaper Pages: 163 - 167

13. Web alert

    • Robert Chilton

    Announcement Pages: 168 - 168